David H. Regan

Compass Oncology — United States

Medicine · Health Sciences

8h-index1.4kcitations19works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Erythropoietin and Anemia Treatment(6), Iron Metabolism and Disorders(4), Economic and Financial Impacts of Cancer(4), Hemoglobinopathies and Related Disorders(3), Health Systems, Economic Evaluations, Quality of Life(3)

Publications19 total

Rate of pathologic fractures associated with zoledronic acid treatment in both breast and prostate cancer patients with bone metastases: Findings from real-world clinical practice.
Journal of Clinical Oncology·2012
American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer
Journal of Clinical Oncology·2010· 300 citedOpen Access
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
Blood·2010· 204 citedOpen Access
In Reply
Journal of Clinical Oncology·2008Open Access
Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update
Journal of Clinical Oncology·2007· 322 citedOpen Access
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update
Blood·2007· 150 citedOpen Access
Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology
Journal of Clinical Oncology·2002· 418 cited
Access to Quality Cancer Care
Oncology Issues·2001
Lessons Learned from Managed Care Mania
Oncology Issues·2001
Well, What's Next?
Oncology Issues·2000· 1 cited
Evaluation: Continued Need for Randomized Trials
Journal of Clinical Oncology·2000· 1 cited
Patients May Lose Out on New Cancer Therapy Options
Oncology Issues·2000
Stop the Potential Collapse of the Cancer Care Delivery System
Oncology Issues·2000
ACCC's New President Speaks Out…
Oncology Issues·2000
The Oncology Nurse: A Vital Discipline in Cancer Care
Oncology Issues·2000
Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Hematopoietic Growth Factor PIXY321 After Moderate-Dose Fluorouracil, Doxorubicin, and Cyclophosphamide in Stage II and III Breast Cancer
Journal of Clinical Oncology·1999· 15 cited
Acquisition Cost Proposals: The End of Community-Based Cancer Care?
Oncology Issues·1999
Effects of behavioral stimuli on plasma interleukin-1 activity in humans at rest
Journal of Clinical Psychology·1993· 8 cited
Defibrination syndrome: changing concepts and recognition of the low grade form
The American Journal of the Medical Sciences·1973· 10 cited

Frequent Co-authors

J. Douglas Rizzo(6), Jerome Seidenfeld(6), Matthew J. Goode(6), Ann A. Jakubowski(6), Charles L. Bennett(5), Mark R. Somerfield(5), Julia Bohlius(5), Alan Lichtin(4), David Cella(4), Benjamin Djulbegović(4), Mark U. Rarick(4), Karen L. Hagerty(3), Carole B. Miller(2), Melissa Brouwers(2), Patricia A. Hurley(2), Murat O. Arcasoy(2), Jerry L. Spivak(2), Darren Evanchuk(2), Steven H. Woolf(1), Stephanie J. Lee(1)